Invention Grant
- Patent Title: Anti-CD70 antibody drug conjugates
-
Application No.: US14410021Application Date: 2013-06-19
-
Publication No.: US10208123B2Publication Date: 2019-02-19
- Inventor: Richard S. Barnett , Nick Knudsen , Ying Sun , Sandra Biroc , Timothy Buss , Tsotne Javahishvili , Damien Bresson , Shailaja Srinagesh , Amha Hewet , Jason K. Pinkstaff
- Applicant: Ambrx, Inc.
- Applicant Address: US CA La Jolla
- Assignee: Ambrx, Inc.
- Current Assignee: Ambrx, Inc.
- Current Assignee Address: US CA La Jolla
- Agent Sharon Beresford
- International Application: PCT/US2013/046669 WO 20130619
- International Announcement: WO2013/192360 WO 20131227
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61P35/00 ; C07K16/28 ; A61K47/42 ; C07K5/062 ; A61K47/68

Abstract:
This invention relates to anti-CD70 antibodies and antibody drug conjugates comprising at least one non-naturally-encoded amino acid. Disclosed herein are αCD70 antibodies with one or more non-naturally encoded amino acids and further disclosed are antibody drug conjugates wherein the αCD70 antibodies of the invention are conjugated to one or more toxins. Further disclosed are methods for using such non-natural amino acid antibody drug conjugates, including therapeutic, diagnostic, and other biotechnology uses.
Public/Granted literature
- US20150141624A1 Anti-CD70 Antibody Drug Conjugates Public/Granted day:2015-05-21
Information query
IPC分类: